跳至主要内容
临床试验/ITMCTR2100004565
ITMCTR2100004565招募中未知

Based on the actual clinical research of real-world traditional Chinese medicine in the treatment of chronic liver failure

The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • 1. Inpatients who meet the diagnostic criteria of chronic liver failure in the 2018 Guidelines for the Diagnosis and Treatment of Liver Failure;
  • 2. Patients with previous liver cirrhosis;
  • 3. Age between 18 and 65 years old, regardless of gender;
  • 4. Those who voluntarily participated in this study and signed the informed consent.

排除标准

  • 1. Acute liver failure, subacute liver failure, chronic acute liver failure;
  • 2. Chronic liver failure caused by other causes (including autoimmune, drug, toxicity and parasitic);
  • 3. Pregnant or lactating women;
  • 4. Patients with primary liver cancer;
  • 5. Patients with other serious systemic diseases and mental illnesses;
  • 6. Anti-HIV positive persons;
  • 7. Those who have participated in other clinical trials within the past 3 months;
  • 8. Those who are unwilling to cooperate;
  • 9. At the time of enrollment, he had been combined with cerebral edema, severe infection (including septic shock, deep fungal infection, infection of more than two sites and double infection, etc.), type I hepatorenal syndrome (clinical features are severe, rapid, and progressive renal Failure, oliguria within a few days or 2 weeks, CRE > 221µmol/L), hepatopulmonary syndrome, hepatic encephalopathy above grade III, and gastrointestinal hemorrhage.

研究者

相似试验